Biotech · Private company
Affini-T Therapeutics, Inc.
Track this companyFree. Adds Affini-T Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- AFNT-211Phase 2 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid TumorPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 6, 2024ClinicalTrials.gov NCT06105021 · fetched Nov 12, 2026
- T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon CancerPHASE1 · RECRUITING · started Dec 15, 2023ClinicalTrials.gov NCT06043713 · fetched Nov 12, 2026
- Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell CancerPHASE1_PHASE2 · TERMINATED · started Jul 3, 2019ClinicalTrials.gov NCT03747484 · fetched Nov 12, 2026